Ads
related to: regeneron monoclonal antibodies
Search results
Regeneron (REGN) Q4 Earnings & Sales Beat, Eylea Sales Decline
Zacks via Yahoo Finance· 1 year agoRegeneron Pharmaceuticals, Inc. REGN delivered better-than-expected fourth-quarter 2022 results even...
Regeneron (REGN) Down 1.4% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 2 years agoA month has gone by since the last earnings report for Regeneron (REGN). Shares have lost about 1.4%...
Regeneron (REGN) to Buy Sanofi's Stake in Libtayo, Stock Down
Zacks via Yahoo Finance· 2 years agoRegeneron Pharmaceuticals REGN announced that it will purchase partner Sanofi’s SNY stake in their...
Biohaven doses first subject in Phase I/II tumour treatment study
Clinical Trials Arena via Yahoo Finance· 1 day agoBiohaven has dosed the first subject in its Phase I/II clinical trial of BHV-1510, a trophoblast...
Will Loss of REGEN-COV Sales Hurt Regeneron (REGN) in 2022?
Zacks via Yahoo Finance· 2 years agoBiotech giant Regeneron Pharmaceuticals REGN witnessed a massive surge in sales in 2021, driven by...
Regeneron (REGN) to Report Q2 Earnings: What's in Store?
Zacks via Yahoo Finance· 10 months agoRegeneron Pharmaceuticals, Inc. REGN is scheduled to release second-quarter 2023 results on Aug 3,...
Regeneron's (REGN) Lymphoma Candidate Rejected by the FDA
Zacks via Yahoo Finance· 2 months agoRegeneron Pharmaceuticals, Inc. REGN suffered a setback as the FDA issued Complete Response Letters...
Is Regeneron Pharmaceuticals Inc (REGN) Modestly Overvalued?
GuruFocus.com via Yahoo Finance· 9 months agoRegeneron Pharmaceuticals Inc (NASDAQ:REGN) reported a daily gain of 1.97% and a 3-month gain of...
Regeneron (REGN) Outperforms YTD: What's in Store for 2023?
Zacks via Yahoo Finance· 2 years agoRegeneron Pharmaceuticals, Inc. REGN is having a good run, with shares gaining 16.4% in the year so...
Regeneron Pharmaceuticals Inc: A Deep Dive into Its Financial Metrics and Competitive Strengths
GuruFocus.com via Yahoo Finance· 9 months agoRegeneron Pharmaceuticals Inc (NASDAQ:REGN) has recently been in the spotlight, drawing interest...
